SchalmSW, de KnegtR.J.. Acute liver failure: definitions and pathological variants. In: WilliamsR., HughesR.D., eds. Acute liver failure: improved understanding and better therapy.London: Miter Press, 1991; 11–3.
3.
EdmondJ.C., AranP.P., WhitingtonP.F., BroelschC.E., BakerA.L.. Liver transplantation in the management of fulminant hepatic failure.Gastroenterology1989; 96: 1583–8.
4.
NybergS.L., ShatfordR.A., HuW.S., PayneW.D., CerraF.B.. Hepatocyte culture systems for artificial liver support: implications for critical care medicine.Crit Care Med.1992; 8: 1157–68.
MargulisM.S., ErukhimovE.A., AndreimanL.A.. Hemoperfusion through suspension of cryopreserved hepatocytes in the treatment of patients with acute liver failure.Research in Surgery1990; 2: 99–102.
7.
NeuzielD.F., RozgaJ., MoscioniA.D.. Use of a novel bioartificial liver in a patient with acute liver insufficiency.Surgery1993; 113: 340–3.
8.
SussmanN.L., KellyJ.H.. Improved liver function following treatment with an extracorporeal liver assist device.Artif Organs1993; 17: 43–5.
9.
RozgaJ., PodestraL., LePageE.. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure.Lancet1993; 342: 898–9.
10.
TreyC., DavidsonC.L.. The management of fulminant hepatic failure.Progress in Liver Disease1970; 3: 282–98.
11.
BernuauJ., BenhamouJ.P., RueffB.. Fulminant and Subfulminant liver failure: definition and causes.Semin Liver Dis1986; 6: 97–106.
12.
European association for the study of the liver. Randomized trial of steroid therapy in acute liver failure.Gut1987; 20: 20–3.
13.
O'GradyJ.G., GlmsonA.E.S., O'BrienC.J.. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.Gastroenterology1988; 94: 1186–92.
14.
Ring-LarsenH., PalazzoV.. Renal failure in fulminant hepatic failure and terminal cirrhosis.Gut1985; 22: 585–91.
15.
O'GradyJ.G., WilliamsR.S.. Acute Hepatic Failure. In: TinkerZapol, eds. Care of the Critically III Patient.2 Ed.Springer1992; 609–31.
16.
BlackM.. Isoniacid-associated hepatitis in 114 patients.Gastroenterology1975; 69: 389–94.
Summary of the National Halothane Study.Possible association between halothane anesthesia and postoperative hepatic necrosis. National Academy of Science.JAMA1963; 197: 775–83.
19.
RuprahM., MantT.G., FlanaganR.J.. Acute carbon tetrachloride poisoning in 19 patients. Implications to diagnosis and treatment.Lancet1985; 1: 1027–9.
20.
HanrahanF.P., GordonM.A.. Mushroom poisoning. Case reports and a review of therapy.JAMA1984; 251: 1057–61.
21.
LichtH., SeeffL.B.. Zimmermann HJ. Apparent potentiation of acetaminophen-toxicity by alcohol.Ann Intern Med1980; 92: 511.
22.
KumarS.. Rex DK. Failure of physicians to recognize acetaminophen hepatoxicity in chronic alcoholics.Arch Intern Med1991; 151: 1189–91.
23.
NouelO., HenrionJ., BernuauJ.. Fulminant hepatic failure due to transient circulatory failure in patients with chronic heart disease.Dig Dis Sci1980; 25: 49–52.
24.
SandleGl, LaytonM., RecordC.O., CowanW.K.. Fulminant hepatic failure due to Budd-Chiari syndrome.Lancet1980; 1: 1199.
HarrisonP.M., KeaysR., BrayG.P., AlexanderG.J.M., WilliamsR.. Improved outcome of paracetamol-induced fulminant hepatic failure by late admission of acetylcysteine.Lancet1990; 335: 1572–3.
O'GradyJ.G., GimsonA.E.S., O'BrienC.J., PucknellA., HughesR.D., WilliamsR.. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.Gastroenterology1988; 94: 1186–92.
41.
CanaleseJ., GimsonA.E., DavisC., MellonP.J., DavisM., WilliamsR.. Controlled trial of dexamethasone and mannitol for the cerebral edema of fulminant hepatic failure.Gut1982; 23(7): 625–9.
ZieveL., AndersonW.R., LindbladS.. Course of hepatic regeneration after 80% to 90% resection of normal rat liver.J Lab Clin Med March; 1985; 331–6.
47.
PackG.T., IsalamiA.H., HubbardJ.C., BrasfieldR.D.. Regeneration of human liver after major hepatectomy.Surgery1962; 52: 617–23.
48.
BengmarkS.. Liver regeneration. In: PackG.T., IslamiA.H., eds. Tumors of the liver.Berlin: Springer Verlag, 1970; 187–210.
49.
ScottoJ., OpolonP., EteveJ.. Liver biopsy and prognosis in acute liver failure.Gut1973; 14: 927–33.
50.
StarzlT.E., GrothC.G., BrettschneiderL.. Orthotopic homotransplantation of the human liver.Ann Surg1968; 168: 392–415.
51.
NeuhausP., BlumhardG., BechsteinW.O.. Comparison of FK 506- and Cyclosporine- based immunosuppression in primary orthotopic liver transplantation.Transplantation1995; 59: (in press).
52.
GordonR.D., FungJ., TzakisA.G.. Liver transplantation at the University of Pittsburgh, 1984 to 1990.Clin Transpl1991; 105–17.
McDiarmidS.V., KlintmalmG.B., BusuttilR.W.. FK 506 conversion for intractable rejection of the liver allograft.Transplant Int1993; 6: 305–12.
59.
NeuhausP., KeckH., BechsteinW.O.. Quadruple induction of immunosuppression after liver transplantation with II-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy.Transpl Proc1993; 25(1): 587–9.
60.
StarzlT.E., iwatsukiS.I., EsquivelC.. Refinements in the surgical technique of liver transplantation.Semin Liver Dis1985; 5: 349.
61.
NeuhausP., BlumhardtG., BechsteinW.O., SteffenR., KeckH.. Side-to-side anastomosis of the common bile duct is the method of choice for biliary tract reconstruction after liver transplantation.Transplant Proc1990; 22: 1571.
62.
NeuhausP., BlumhardtG., BechsteinW.O., SteffenR., PlatzK-P, KeckH.. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants.Ann Surg1994; 219(4): 426–34.
63.
NeuhausP., BrölschC., RingeB., LauchartW., PichlmayrR.. Results of biliary reconstruction after liver transplantation.Transplant Proc1984; 16(5): 1225–7.
64.
CoferJ.B., KlintmalmG.B., HowardT.K.. A comparison of UW with Eurocollins preservation solution in liver transplantation.Transplantation1990; 49(6): 1088–93.
65.
WahlbergJ.A., SouthardJ.A., BelzerF.O.. Development of a cold storage solution for pancreas preservation.Cryobiology1986; 23: 477.
66.
JamiessonN.V., SundbergR., LindellS.. Preservation of the canine liver for 24–48 hours simple cold storage UW solution.Transplantation1988; 46(4): 517–25.
67.
KalayogluM., SollingerH.W., StrattaR.J., HoffmannR.M., BelzerF.O.. Extended preservation of the liver for clinical transplantation.Lancet1988; 2: 617–9.
68.
ClavienP.A., HarveyP.R.C., StrasbergS.M.. Preservation and reperfusion injuries in liver allografts.Transplantation1992; 53: 957–78.
69.
StrasbergS.M., ToddK.H., MolmentiE.P., HertlM.. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation.Hepatology1994; 20: 829–38.
70.
KamathG.S., PlevakD.J., WiesnerR.H.. Primary nonfunction of the liver graft: when should we retransplant?Transplant Proc1991; 23(3): 1954.
71.
DeRisoB.M.. Postoperative care following hepatic transplantation. In: TinkerZapol, eds. Care of the critically ill patient, 2 Ed, Springer1992; 621–31.
72.
KnechtleS., D'AlessandroA., ReedA.. Liver transplantation: the university of Wisconsin experience.Transplant Proc1991; 23(3): 1955.
73.
RingeB., NeuhausP., LauchartW.. Experience with hepatic retransplantation.Transplant Proc1989; 21(1): 2407–8.
74.
ShawB.W., WoodR.P.. Improved results with retransplantation of the liver.Transplantation1989; 21(1): 2407–8.
75.
AgnesS., AvolioA.W., MagaliniS.C., FocoM., CastagnetoM.. Should retransplantation still be considered for primary non-function after liver transplantation?Transpl lnt1992; S170–2.
76.
GreigP.D., WoolfG.M., AbecassisM.. Prostaglandin E, for primary nonfunction following liver transplantation.Transplant Proc1989; 21(2): 3360–1.
77.
McCaughanG.W., HuynhJ.C., FellerR., PainterD., WaughR., SheilA.G.R.. Fulminant hepatic failure post liver transplantation: clinical syndromes, correlations and outcomes.Transpl Int1995; 8: 20–6.
78.
MoraN.P., KlintmalmG.B., CoferJ.B.. Result after liver retransplantation (RETx): a comparative study between “elective” vs “nonelective” RETx.Transplant Proc1990; 22: 1509–11.
79.
PowelsonJ.A., CosimiA.B., LewisW.D., VacantiJ.P., MarksW.H., JenkinsR.L.. Hepatic retransplantation in New England - a regional experience and survival model.Transplantation1993; 55: 802–6.